Groningen hospital researching possible coronavirus medicine
4 years, 9 months ago

Groningen hospital researching possible coronavirus medicine

NL Times  

Reserachers at the University Medical Center Groningen are working on a possible medicine against coronavirus Covid-19. They are trying to make two commonly used, safe and cheap malaria medicines suitable for an inhaler, so that the medicine can get deep into the airway and protect against infection there, NOS reports. They are currently used in intensive care units around the world on critically ill Covid-19 patients, and appear to have a positive effect. About 70 of them responded favorably to the medicine, becoming less ill than people who did not get it.

Medicine Groningen  working  coronavirus  covid19  work  possible  world  malaria  groningen  ill  medicines  researching  used  hospital  medicine

History of this topic

"Hundreds" of Dutch died from hydroxychloroquine side effects during Covid pandemic
1 year ago

"Hundreds" of Dutch died from hydroxychloroquine side effects during Covid pandemic

NL Times  

In the early phase of the coronavirus pandemic, several hundred Dutch people died from the side effects of hydroxychloroquine, the malaria drug that seemed promising against COVID-19. And laboratory research showed that this drug might work.” Of the COVID-19 patients treated in Dutch hospitals, an estimated 10,000 or so were given hydroxychloroquine, and about 2,000 ultimately died, Bonten said. “If …

WHO trial to study potential of 3 anti-malarial drugs against Covid
3 years, 4 months ago

WHO trial to study potential of 3 anti-malarial drugs against Covid

India TV News  

The World Health Organisation has announced a clinical trial to study three antimalarial and anti-inflammatory drugs as potential treatments for patients with Covid. The drugs -- artesunate, imatinib, and infliximab -- were selected by an independent expert panel for their potential in reducing the risk of death in hospitalized Covid-19 patients, the WHO said in a statement. "Finding more effective …

WHO to trial malaria, arthritis drugs as COVID treatments
3 years, 4 months ago

WHO to trial malaria, arthritis drugs as COVID treatments

Al Jazeera  

Three drugs will be added to the UN agency’s global trial to test their efficacy in patients hospitalised with COVID-19. The World Health Organization will test three new drugs as potential treatments for people in hospital with severe COVID-19 as it expands its global trial to 52 countries. Artesunate is currently used for severe malaria, imatinib for certain cancers, and …

WHO Tests 3 Drugs for Treating Coronavirus Infection
3 years, 4 months ago

WHO Tests 3 Drugs for Treating Coronavirus Infection

News 18  

The World Health Organization says it will soon test three drugs used for other diseases to see if they might help patients sickened by the coronavirus. In a statement on Wednesday, the U.N. health agency says the three drugs would be adopted into the next phase of its ongoing global research into identifying potential treatments for COVID-19. The drugs were …

Anti-malarial drug shows promise in treating Covid-19
3 years, 6 months ago

Anti-malarial drug shows promise in treating Covid-19

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy As governments around the world race to vaccinate their populations, scientists …

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO
3 years, 10 months ago

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO

Hindustan Times  

Anti-inflammatory drug hydroxychloroquine should not be used in efforts to prevent infection with Covid-19, according to the World Health Organization. Hydroxychloroquine was touted as a Covid-19 treatment by former President Donald Trump and later deemed ineffective. The WHO’s recommendation is based on evidence from six randomized controlled trials with more than 6,000 participants with or without known exposure to a …

WHO: Study finds four drugs that have little to no effect on coronavirus, including remdesivir
4 years, 2 months ago

WHO: Study finds four drugs that have little to no effect on coronavirus, including remdesivir

India Today  

The World Health Organisation announced Friday the long-awaited results of its six-month “Solidarity Therapeutics Trial” that endeavored to see if existing drugs might have an effect on the coronavirus. What the study found The study, which was not peer-reviewed, found that four treatments tested - remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon - had “ little or no effect" on whether or …

Hydroxycloroquine does not help with Covid mortality; Improves ICU risk
4 years, 2 months ago

Hydroxycloroquine does not help with Covid mortality; Improves ICU risk

NL Times  

Hydroxychloroquine, a malaria drug often used to treat Covid-19, does not have a noticeable effect on the mortality rate of the coronavirus, according to a study by 14 Dutch hospitals. The hospitals analyzed 1,064 Covid-19 patients in 14 hospitals, 189 of whom were treated with hydroxychloroquine, 377 were treated with chloroquine, and 498 were not treated with either of the …

Anti-malaria drug hydroxychloroquine ineffective against coronavirus, reveal UK RECOVERY Trials
4 years, 3 months ago

Anti-malaria drug hydroxychloroquine ineffective against coronavirus, reveal UK RECOVERY Trials

Firstpost  

The results of the study, published by NEJM, showed that COVID-19 patients who did not need mechanical ventilation to begin with had a higher likelihood of needing ventilation or dying when they were put on hydroxychloroquine Hydroxychloroquine is no better than usual care in reducing the chances of death in COVID-19 patients, suggest the results of RECOVERY Trials published Thursday …

Amsterdam study shows hydroxychloroquine ineffective in Covid-19 treatment
4 years, 4 months ago

Amsterdam study shows hydroxychloroquine ineffective in Covid-19 treatment

NL Times  

Hydroxychloroquine was not effective in treating Covid-19 in Dutch hospitals during the coronavirus crisis, according to a study by Amsterdam scientists led by internist-infectiologist Edgar Peters of Amsterdam UMC. The Amsterdam researchers compared seven hospitals where Hydroxychloroquine was included in the treatment guideline in the early months of the crisis, to two hospitals where the drug was not prescribed. In …

Everything you wanted to know about covid-19 treatments, in five charts
4 years, 5 months ago

Everything you wanted to know about covid-19 treatments, in five charts

Live Mint  

When India’s National Task Force on COVID-19 recommended against including Itolizumab, Biocon’s psoriasis drug, in its treatment guidelines, the move represented two key aspects of the global scramble for a cure for covid-19 - the problematic bar for evidence, as well as the sheer size of the challenge. Perhaps no drug candidate in the race for a cure for covid-19 …

Where are we in finding a treatment for COVID-19?
4 years, 5 months ago

Where are we in finding a treatment for COVID-19?

Al Jazeera  

Some drugs and treatments have shown promise in clinical trials, while others are drawing controversy. More information on the efficacy of remdesivir in patients with COVID-19 is expected from large clinical trials such as the WHO-coordinated Solidarity Trial and the Recovery Trial in the United Kingdom. “It’s really important that these drugs be evaluated in robust clinical trials before being …

Hydroxychloroquine is a poor coronavirus treatment but a perfect parable for our times
4 years, 5 months ago

Hydroxychloroquine is a poor coronavirus treatment but a perfect parable for our times

ABC  

The group had all the trappings of medical authority. Since March 1, public posts containing the word "hydroxychloroquine" have received at least 55 million "interactions" on Facebook — a measure that includes reactions, shares or comments. And in the months since, President Trump and members of his administration have repeatedly returned to the hydroxychloroquine narrative despite the protests of White …

Trump Defends Use of Hydroxychloroquine, Says It Works in Early Stages of Covid-19 Infection
4 years, 5 months ago

Trump Defends Use of Hydroxychloroquine, Says It Works in Early Stages of Covid-19 Infection

News 18  

US President Donald Trump has again defended the use of hydroxychloroquine to ward off coronavirus, saying many frontline medical workers agree with him that the malaria drug works in the early stages of COVID-19 infection, despite mounting evidence that it is ineffective in treating the disease. I think frontline medical people believe that too — some, many," Trump told reporters …

Scientists identify 21 existing drugs that block coronavirus in lab studies
4 years, 5 months ago

Scientists identify 21 existing drugs that block coronavirus in lab studies

Live Mint  

Scientists, including those of Indian-origin, have identified 21 existing drugs that stop the replication of the novel coronavirus which causes COVID-19 in lab studies, an advance that may lead to the development of new therapeutic combinations against the disease. Of the 21 drugs that were effective at blocking viral replication, the scientists found that 13 have previously entered clinical trials …

New studies clarify what drugs help, hurt for COVID-19
4 years, 5 months ago

New studies clarify what drugs help, hurt for COVID-19

Associated Press  

Fresh studies give more information about what treatments do or don’t work for COVID-19, with high-quality methods that give reliable results. It reduced deaths by 36% for patients sick enough to need breathing machines: 29% on the drug died versus 41% given usual care. After 28 days, about 25.7% on hydroxychloroquine had died versus 23.5% given usual care -- a …

Brazil hospitals overwhelmed as coronavirus cases cross 2 million
4 years, 5 months ago

Brazil hospitals overwhelmed as coronavirus cases cross 2 million

Al Jazeera  

Health authorities struggling to cope and treat COVID-19 patients as virus spreads to smaller cities in the country. At a public hospital in the city of Campinas, northwest of Sao Paulo, a video recorded by a doctor who works at the facility showed no intensive care unit beds available to treat COVID-19 patients. “We’ve had many days with a 100 …

July 16 coronavirus news
4 years, 5 months ago

July 16 coronavirus news

CNN  

A pharmacy tech pours out hydroxychloroquine pills in May. George Frey/AFP/Getty Images The antimalarial drug hydroxychloroquine did not benefit non-hospitalized patients with mild symptoms from Covid-19 who were treated early in their infection, according to a study to be published Thursday in the medical journal Annals of Internal Medicine. “Taken together, there is no convincing evidence that hydroxychloroquine can either …

Hydroxychloroquine doesn’t work in non-hospitalized patients
4 years, 5 months ago

Hydroxychloroquine doesn’t work in non-hospitalized patients

CNN  

CNN — The antimalarial drug hydroxychloroquine did not benefit non-hospitalized patients with mild Covid-19 symptoms who were treated early in their infection, according to a study published Thursday in the medical journal Annals of Internal Medicine. “Taken together, there is no convincing evidence that hydroxychloroquine can either prevent COVID-19 after exposure or reduce illness severity after developing early symptoms,” study …

No room for complacency, says PM Modi after COVID-19 review
4 years, 5 months ago

No room for complacency, says PM Modi after COVID-19 review

The Hindu  

Prime Minister Narendra Modi on Saturday, following a COVID-19 review meeting with Home Minister Amit Shah, Health Minister Harsh Vardhan and other senior government officials, reiterated the need to observe personal hygiene and social discipline in public places while appreciating the manner in which the pandemic has been “contained” in Delhi. “There are 2,83,407 active cases and all are under …

US prescriptions for hydroxychloroquine skyrocketed from February to March, study finds
4 years, 6 months ago

US prescriptions for hydroxychloroquine skyrocketed from February to March, study finds

CNN  

CNN — Prescriptions for the anti-malarial drugs chloroquine and hydroxychloroquine skyrocketed in the US from February to March, a time when the drugs, though unproven, were touted as treatments for the coronavirus. Researchers found the estimated number of hydroxychloroquine prescriptions increased 86.2% from February to March, from 367,346 to 683,999, and dispensed chloroquine prescriptions increased 158.6%, rising from 2,346 to …

WHO ending hydroxychloroquine trial for COVID
4 years, 6 months ago

WHO ending hydroxychloroquine trial for COVID

LA Times  

The World Health Organization says it is ending a trial into whether the anti-malaria drug hydroxychloroquine helps patients hospitalized with COVID-19. The WHO said Saturday it has “accepted the recommendation” from the committee overseeing the trial to discontinue testing of hydroxychloroquine and lopinavir/ritonavir, a drug combination used to treat HIV/AIDS. The United Nations agency says a review of the interim …

Study finds hydroxychloroquine helped coronavirus patients survive better
4 years, 6 months ago

Study finds hydroxychloroquine helped coronavirus patients survive better

CNN  

CNN — A surprising new study found the controversial antimalarial drug hydroxychloroquine helped patients better survive in the hospital. A team at Henry Ford Health System in southeast Michigan said Thursday their study of 2,541 hospitalized patients found that those given hydroxychloroquine were much less likely to die. The US Food and Drug Administration withdrew its emergency use authorization for …

Hydroxychloroquine: US stockpile stuck with 63 million doses of the drug
4 years, 6 months ago

Hydroxychloroquine: US stockpile stuck with 63 million doses of the drug

CNN  

CNN — The federal government is stuck with 63 million doses of hydroxychloroquine now that the US Food and Drug Administration has revoked permission for the drug to be distributed to treat coronavirus patients. The government started stockpiling donated hydroxychloroquine in late March, after President Trump touted it as “very encouraging” and “very powerful” and a “game-changer.” But Monday, the …

Coronavirus | Dexamethasone reduces deaths from COVID-19, say researchers in U.K.
4 years, 6 months ago

Coronavirus | Dexamethasone reduces deaths from COVID-19, say researchers in U.K.

The Hindu  

Researchers in the U.K. say they have the first evidence that a drug can improve COVID-19 survival: A steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalised patients. The study is a large, strict test that randomly assigned 2,104 patients to get the drug and compared them with 4,321 patients getting only usual care. “The …

Steroid drug: A ‘breakthrough’ in the fight against coronavirus?
4 years, 6 months ago

Steroid drug: A ‘breakthrough’ in the fight against coronavirus?

Al Jazeera  

UK has approved the drug use in the state-run health service and stockpiled 200,000 courses of the treatment. A cheap and widely-used steroid called dexamethasone has become the first drug shown to be able to save lives among COVID-19 patients in what scientists said is a “major breakthrough” in the coronavirus pandemic. “This is a result that shows that if …

US revokes emergency use of drugs touted by Trump vs. virus
4 years, 6 months ago

US revokes emergency use of drugs touted by Trump vs. virus

Associated Press  

WASHINGTON — U.S. regulators on Monday revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause serious side effects. Citing reports of heart complications, the FDA said the drugs’ unproven benefits “do not outweigh the known and potential risks.” In a separate announcement, the FDA also warned …

FDA revokes emergency use authorisation for hydroxychloroquine
4 years, 6 months ago

FDA revokes emergency use authorisation for hydroxychloroquine

The Hindu  

On June 15, the U.S. Food and Drug Administration revoked the emergency use authorization issued for two drugs — hydroxychloroquine sulfate and chloroquine phosphate — for use in certain hospitalised COVID-19 patients. The FDA further added: “In light of ongoing serious cardiac adverse events and other serious side effects, the known and potential benefits of CQ and HCQ no longer …

FDA Withdraws Emergency Use Authorization For Hydroxychloroquine
4 years, 6 months ago

FDA Withdraws Emergency Use Authorization For Hydroxychloroquine

NPR  

FDA Withdraws Emergency Use Authorization For Hydroxychloroquine toggle caption David J. Phillip/AP The U.S. Food and Drug Administration today withdrew a special status known as emergency use authorization for the drugs chloroquine and hydroxychloroquine. Emergency use authorization is designed to facilitate the availability of drugs needed during public health emergencies. The FDA granted the emergency use authorization in March. "It …

Coronavirus | Avoid hydroxychloroquine in COVID-19 patients with severe disease, says Health Ministry protocol
4 years, 6 months ago

Coronavirus | Avoid hydroxychloroquine in COVID-19 patients with severe disease, says Health Ministry protocol

The Hindu  

The Health Ministry on Saturday said the anti-malarial drug hydroxychloroquine should be used as early as possible in the course of coronavirus treatment to achieve any meaningful effects and should be avoided in patients with severe disease. Hydroxychloroquine clinical trials will resume, says WHO A 22-page new, national clinical management protocol provides for the management of COVID-19 cases based on …

Health Ministry okays HCQ for early course of Covid-19, remdesivir under emergency use
4 years, 6 months ago

Health Ministry okays HCQ for early course of Covid-19, remdesivir under emergency use

India Today  

The Union Health Ministry has recommended the use of anti-viral drug remdesivir under emergency use authorization, off-label application of immunomodulator tocilizumab and convalescent plasma therapy for treating Covid-19 patients in moderate stage of criticality. Backtracking from its earlier stance, the ministry said anti-malarial drug hydroxychloroquine should be used in the early course of the disease to achieve any meaningful effect …

Govt reviews use of HCQ and antibiotic combo in treating coronavirus cases
4 years, 6 months ago

Govt reviews use of HCQ and antibiotic combo in treating coronavirus cases

Hindustan Times  

The Union health ministry is reviewing use of anti-malarial drug hydroxychloroquine, in combination with antibiotic azithromycin, for treating coronavirus disease on patients in India, and is likely to come up with revised clinical management guidelines for this soon. The drug hydroxychloroquine, pushed by US President Donald Trump and others in recent months as a possible treatment to people infected with …

UK halts hydroxychloroquine trial after experts find no reduction in risk of death among coronavirus patients
4 years, 7 months ago

UK halts hydroxychloroquine trial after experts find no reduction in risk of death among coronavirus patients

Firstpost  

British scientists halted a major drug trial after it found that the anti-malarial hydroxychloroquine was ‘useless’ at treating COVID-19 patients London: British scientists halted a major drug trial on Friday after it found that the anti-malarial hydroxychloroquine, touted by US President Donald Trump as a potential “game changer” in the pandemic, was “useless” at treating COVID-19 patients. We can now …

UK Covid-19 trial ends hydroxychloroquine study because there’s no evidence the drug benefits patients
4 years, 7 months ago

UK Covid-19 trial ends hydroxychloroquine study because there’s no evidence the drug benefits patients

CNN  

CNN — Researchers in the United Kingdom have put an abrupt stop to an arm of their Covid-19 trial that involves the antimalarial drug hydroxychloroquine. The Recovery trial, a large UK-based trial investigating potential coronavirus treatments, has stopped including hydroxychloroquine in its study due to there being “no evidence of benefit,” researchers announced on Friday. “We reviewed the data and …

Malaria drug fails to prevent COVID-19 in a rigorous study
4 years, 7 months ago

Malaria drug fails to prevent COVID-19 in a rigorous study

Associated Press  

A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease. “This fits with everything else we’ve seen so far which suggests that it’s not beneficial,” said Dr. Peter Bach, director of a health policy center …

Coronavirus | Hydroxychloroquine clinical trials will resume, says WHO
4 years, 7 months ago

Coronavirus | Hydroxychloroquine clinical trials will resume, says WHO

The Hindu  

The World Health Organisation said on Wednesday that clinical trials of the drug hydroxychloroquine will resume, after having been suspended pending a safety review in the search for coronavirus treatments. Concerns about data British medical journal The Lancet said on Tuesday that it had concerns about data behind an influential article that found that HCQ increased the risk of death …

Hydroxychloroquine sustained dose and PPE can reduce COVID-19 risk in healthcare workers, ICMR study says
4 years, 7 months ago

Hydroxychloroquine sustained dose and PPE can reduce COVID-19 risk in healthcare workers, ICMR study says

Firstpost  

ICMR continues to insist that the anti-malarial drug has the potential to minimise the chances of healthcare workers contracting the novel coronavirus. The World Health Organization and a recent study in The Lancet might have thrown doubt on the prophylactic benefits of hydroxychloroquine in reducing COVID-19 risks, but the Indian Council of Medical Research continues to insist that the anti-malarial …

Coronavirus Outbreak: Two studies that showed Hydroxychloroquine's negative effects on COVID-19 patients are being called into question
4 years, 7 months ago

Coronavirus Outbreak: Two studies that showed Hydroxychloroquine's negative effects on COVID-19 patients are being called into question

Firstpost  

The study conducted on around 10,000 people tie the malaria drugs to a higher risk of death in hospitalized patients with the virus. After a study published in The Lancet Journal claimed that administering hydroxychloroquine to people infected with COVID-19 infection can increase their risk of death, the World Health Organisation suspended a large scale trial on COVID-19 patients. Now, …

Malaria drug fails to prevent COVID-19 in a rigorous study
4 years, 7 months ago

Malaria drug fails to prevent COVID-19 in a rigorous study

LA Times  

A malaria drug that President Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease. After 14 days in the study, 12% on the drug developed COVID-19 symptoms versus 14% in the placebo group, but the difference is so small …

Hydroxychloroquine: Trump said he took the drug to prevent coronavirus, but new study shows that doesn’t work
4 years, 7 months ago

Hydroxychloroquine: Trump said he took the drug to prevent coronavirus, but new study shows that doesn’t work

CNN  

CNN — On the heels of studies showing hydroxychloroquine doesn’t help patients in the hospital with Covid-19, a new study – the first of its kind – shows the drug doesn’t work to prevent infection with the virus, either. The University of Minnesota study has been covered in the media over the past few months, and Dr. David Boulware, the …

Coronavirus | Hydroxychloroquine with PPE reduces odds of COVID-19 in health workers: ICMR researchers
4 years, 7 months ago

Coronavirus | Hydroxychloroquine with PPE reduces odds of COVID-19 in health workers: ICMR researchers

The Hindu  

More than four doses of hydroxychloroquine, along with the use of personal protective equipment, appeared to protect healthcare workers from sars cov-2, according to the first such published investigation in India on the drug’s preventive effects by researchers at the Indian Council of Medical Research. A scientist involved with the study said that this was due to the limitations of …

Scientists are searching hard for coronavirus treatments. Which ones look promising?
4 years, 7 months ago

Scientists are searching hard for coronavirus treatments. Which ones look promising?

ABC  

Medicinal chemist Derek Lowe has worked in the US pharmaceutical industry for 30 years. "Coronavirus is more complex than HIV because the immune system here is causing a lot of damage in people who are getting sick," Professor Lewin says. "As the days go on we're getting a better understanding of what needs to be targeted: the virus or the …

Questionable ethics: Anti-malaria drug trials on Covid-19 patients continue
4 years, 7 months ago

Questionable ethics: Anti-malaria drug trials on Covid-19 patients continue

NL Times  

Studies are reportedly underway across multiple Dutch hospitals to test the efficacy of the anti-malaria drugs chloroquine and hydroxychloroquine, despite mounting international evidence that their use to treat Covid-19 has little effect. The anti-malaria drugs, which have garnered controversy in recent months for unfounded promises of being a miracle cure, are being tested in ten major Dutch hospitals, including UMC …

France, Italy, Belgium act to stop use of hydroxychloroquine for covid-19 on safety fears
4 years, 7 months ago

France, Italy, Belgium act to stop use of hydroxychloroquine for covid-19 on safety fears

Live Mint  

France, Italy and Belgium acted to halt the use of hydroxychloroquine to treat patients suffering from COVID-19, the illness caused by the new coronavirus, amid questions about the safety of the generic anti-malaria drug. France on Wednesday cancelled a decree allowing hospital doctors to dispense the medicine, while the Italian Medicine Agency suspended authorization to use hydroxychloroquine for COVID-19 outside …

France bans hydroxychloroquine to treat COVID-19 amid safety concerns
4 years, 7 months ago

France bans hydroxychloroquine to treat COVID-19 amid safety concerns

Live Mint  

The French government on Wednesday cancelled a decree allowing hospital doctors to administer hydroxychloroquine as a treatment to patients suffering severe forms of COVID-19, the illness caused by the new coronavirus. The move, which takes immediate effect, is the first by a country since the World Health Organization said on Monday it was pausing a large trial of the malaria …

Anthony Fauci: Science shows hydroxychloroquine is not effective as a coronavirus treatment
4 years, 7 months ago

Anthony Fauci: Science shows hydroxychloroquine is not effective as a coronavirus treatment

CNN  

Washington CNN — Dr. Anthony Fauci said Wednesday that data shows hydroxychloroquine is not an effective treatment for the coronavirus, disputing use of the drug to fight the deadly virus even as President Donald Trump touts it as a potential cure and says he has taken it himself. “The scientific data is really quite evident now about the lack of …

WHO suspends hydroxychloroquine trial for coronavirus patients due to safety concerns
4 years, 7 months ago

WHO suspends hydroxychloroquine trial for coronavirus patients due to safety concerns

ABC  

The World Health Organization has suspended testing of the malaria drug hydroxychloroquine in coronavirus patients due to safety concerns, according to WHO director-general Tedros Adhanom Ghebreyesus. Key points: A study in The Lancet warned that hydroxycholoroquine could cause heart problems Donald Trump said he was taking the drug as a precaution against COVID-19 Other WHO trials will continue, including for …

Coronavirus | WHO suspends clinical trials of hydroxychloroquine over safety concerns
4 years, 7 months ago

Coronavirus | WHO suspends clinical trials of hydroxychloroquine over safety concerns

The Hindu  

The World Health Organization said on Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure. Mr. Tedros said that the executive group of the so-called Solidarity Trial, in which hundreds of hospitals across several countries have enrolled patients to test several possible …

Coronavirus: WHO suspends hydoxychloroquine trial over safety
4 years, 7 months ago

Coronavirus: WHO suspends hydoxychloroquine trial over safety

Daily Mail  

A clinical trial of the anti-malaria drug hydroxychloroquine in coronavirus patients has been suspended amid safety concerns. But the World Health Organization said it was concerned after a study from The Lancet published on Friday revealed higher mortality rates among COVID-19 patients who took the drug. Therefore, researchers said they're suspending use of hydroxychloroquine in the WHO's Solidarity Trial, which …

Safety concerns: WHO halts clinical trial of anti-malaria drug hydroxychloroquine for Covid-19
4 years, 7 months ago

Safety concerns: WHO halts clinical trial of anti-malaria drug hydroxychloroquine for Covid-19

India Today  

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in coronavirus patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday. "The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board," Tedros told an online briefing. …

Discover Related